01 1Orgapharm
01 1Dong-A ST Co., Ltd.
01 1Imiquimod
01 1France
Registrant Name : Dong-A ST Co., Ltd.
Registration Date : 2023-02-15
Registration Number : 20230215-209-J-1446
Manufacturer Name : Orgapharm
Manufacturer Address : Zone Industrielle, Rue du Moulin De La Canne, Pithiviers, 45300, France
95
PharmaCompass offers a list of Imiquimod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Imiquimod manufacturer or Imiquimod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imiquimod manufacturer or Imiquimod supplier.
A Imimore manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Imimore, including repackagers and relabelers. The FDA regulates Imimore manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Imimore API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Imimore manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Imimore supplier is an individual or a company that provides Imimore active pharmaceutical ingredient (API) or Imimore finished formulations upon request. The Imimore suppliers may include Imimore API manufacturers, exporters, distributors and traders.
click here to find a list of Imimore suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Imimore Drug Master File in Korea (Imimore KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Imimore. The MFDS reviews the Imimore KDMF as part of the drug registration process and uses the information provided in the Imimore KDMF to evaluate the safety and efficacy of the drug.
After submitting a Imimore KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Imimore API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Imimore suppliers with KDMF on PharmaCompass.
